Ilyang Pharmaceutical Co Ltd (007575) — Tangible Net Worth Ratio
Ilyang Pharmaceutical Co Ltd (007575) has a Tangible Net Worth Ratio of 89.4% as of June 2025. This metric is calculated by deducting intangible assets (₩25.40 Billion) from net assets (₩239.41 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Ilyang Pharmaceutical Co Ltd (007575) equity growth momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Ilyang Pharmaceutical Co Ltd Tangible Net Worth Ratio (2014–2024)
This chart shows how Ilyang Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 11 annual periods from 2014 to 2024. As of June 2025, the ratio stands at 89.4%, reflecting net assets of ₩239.41 Billion with intangible assets of ₩25.40 Billion KRW. For live market cap and overall valuation, see market value of Ilyang Pharmaceutical Co Ltd.
Annual Tangible Net Worth Ratio for Ilyang Pharmaceutical Co Ltd (2014–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Ilyang Pharmaceutical Co Ltd from 2014 to 2024, covering 11 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore 007575 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 89.5% | ₩241.58 Billion | ₩25.34 Billion | ₩431.21 Billion | ▲ +3.4 pp |
| 2023 | 86.1% | ₩196.41 Billion | ₩27.26 Billion | ₩356.66 Billion | ▲ +11.8 pp |
| 2022 | 74.3% | ₩291.85 Billion | ₩74.90 Billion | ₩498.19 Billion | ▼ -1.7 pp |
| 2021 | 76.0% | ₩271.76 Billion | ₩65.16 Billion | ₩494.27 Billion | ▲ +0.3 pp |
| 2020 | 75.7% | ₩244.92 Billion | ₩59.40 Billion | ₩439.12 Billion | ▼ -0.9 pp |
| 2019 | 76.7% | ₩222.74 Billion | ₩52.00 Billion | ₩437.46 Billion | ▲ +0.8 pp |
| 2018 | 75.8% | ₩209.88 Billion | ₩50.72 Billion | ₩432.25 Billion | ▼ -3.2 pp |
| 2017 | 79.1% | ₩210.98 Billion | ₩44.18 Billion | ₩436.37 Billion | ▲ +3.5 pp |
| 2016 | 75.6% | ₩217.35 Billion | ₩53.13 Billion | ₩431.26 Billion | ▼ -21.9 pp |
| 2015 | 97.4% | ₩211.00 Billion | ₩5.41 Billion | ₩431.63 Billion | ▲ +0.3 pp |
| 2014 | 97.2% | ₩183.46 Billion | ₩5.22 Billion | ₩430.83 Billion | — |